Syros to Host Key Opinion Leader Symposium on CDK7 Inhibition on April 24, 2019
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced…
Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced…
WATERTOWN, Mass.–(BUSINESS WIRE)–1CellBio, Inc., today announced a new program to supply select customers with its proprietary inDrop™ hydrogel beads synthesized…
– E-poster Presented at the 2019 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting – CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics…
Organizations are driving deeper customer insights with end-to-end events management solution seamlessly integrated with CRM PLEASANTON, Calif.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/cloud?src=hash" target="_blank"gt;#cloudlt;/agt;–Veeva…
Organizations are driving deeper customer insights with end-to-end events management solution seamlessly integrated with CRM BARCELONA, Spain–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/lifesciences?src=hash" target="_blank"gt;#lifescienceslt;/agt;–Veeva…
Only twice-daily LAMA /LABA in the United States with COPD exacerbation data included in its prescribing information MORRISVILLE, N.C.–(BUSINESS WIRE)–Circassia…
Well-filled research pipeline in oncology, fibrotic diseases, immunology and metabolic diseases Operating growth outpaces the market in all businesses Technical…
PureTech Health to receive up to $26 million in upfront payments, research support, and preclinical milestones and is eligible to…
GS010-treated eyes showed continuous recovery of visual functions from nadir (worst vision post-treatment) in both best-corrected visual acuity (BCVA) and…
PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With…